These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10414029)

  • 1. Strategies to control the genital herpes epidemic.
    Schinazi RB
    Math Biosci; 1999 Jul; 159(2):113-21. PubMed ID: 10414029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genital herpes infection: a review.
    Brugha R; Keersmaekers K; Renton A; Meheus A
    Int J Epidemiol; 1997 Aug; 26(4):698-709. PubMed ID: 9279600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genital herpes: epidemiology, transmission, clinic, asymptomatic viral excretion, impact on other sexually transmitted diseases, prevention, and treatment].
    Bossi P
    Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):477-93. PubMed ID: 12122319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HSV shedding.
    Sacks SL; Griffiths PD; Corey L; Cohen C; Cunningham A; Dusheiko GM; Self S; Spruance S; Stanberry LR; Wald A; Whitley RJ
    Antiviral Res; 2004 Aug; 63 Suppl 1():S19-26. PubMed ID: 15450382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrupting transmission of genital herpes.
    Griffiths PD
    Rev Med Virol; 2004; 14(2):67-9. PubMed ID: 15026999
    [No Abstract]   [Full Text] [Related]  

  • 6. HSV-2 transmission.
    Sacks SL; Griffiths PD; Corey L; Cohen C; Cunningham A; Dusheiko GM; Self S; Spruance S; Stanberry LR; Wald A; Whitley RJ
    Antiviral Res; 2004 Aug; 63 Suppl 1():S27-35. PubMed ID: 15450383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study.
    Kim HN; Wald A; Harris J; Almekinder J; Heitman C; Corey L
    Sex Transm Dis; 2008 Feb; 35(2):124-8. PubMed ID: 17921912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-collected genital swabs compared with cervicovaginal lavage for measuring HIV-1 and HSV-2 and the effect of acyclovir on viral shedding.
    McNicholl JM; Leelawiwat W; Whitehead S; Hanson DL; Evans-Strickfaden T; Cheng CY; Chonwattana W; Mueanpai F; Kittinunvorakoon C; Markowitz L; Dunne EF
    Int J STD AIDS; 2017 Mar; 28(4):372-379. PubMed ID: 27179350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model of the transmission and control of genital herpes.
    Newton EA; Kuder JM
    Sex Transm Dis; 2000 Aug; 27(7):363-70. PubMed ID: 10949427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antivirals in the prevention of genital herpes.
    Au E; Sacks SL
    Herpes; 2002 Dec; 9(3):74-7. PubMed ID: 12470605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting virological core groups: a new paradigm for controlling herpes simplex virus type 2 epidemics.
    Blower S; Wald A; Gershengorn H; Wang F; Corey L
    J Infect Dis; 2004 Nov; 190(9):1610-7. PubMed ID: 15478066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.
    Wald A; Corey L; Cone R; Hobson A; Davis G; Zeh J
    J Clin Invest; 1997 Mar; 99(5):1092-7. PubMed ID: 9062368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidance on management of asymptomatic neonates born to women with active genital herpes lesions.
    Kimberlin DW; Baley J; ;
    Pediatrics; 2013 Feb; 131(2):383-6. PubMed ID: 23378604
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of antiviral medications in the treatment of herpes simplex virus infections of women.
    Baker DA
    Int J Fertil Womens Med; 1999; 44(5):227-33. PubMed ID: 10569451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acyclovir suppresses subclinical shedding of herpes simplex virus.
    Straus SE; Rooney JF; Hallahan C
    Ann Intern Med; 1996 Nov; 125(9):776-7. PubMed ID: 8929015
    [No Abstract]   [Full Text] [Related]  

  • 16. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
    Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
    J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing the risk of transmitting genital herpes: advances in understanding and therapy.
    Leone P
    Curr Med Res Opin; 2005 Oct; 21(10):1577-82. PubMed ID: 16238897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of perinatal herpes: prophylactic antiviral therapy?
    Scott LL
    Clin Obstet Gynecol; 1999 Mar; 42(1):134-48; quiz 174-5. PubMed ID: 10073307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.
    Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD
    Infect Dis Obstet Gynecol; 2001; 9(2):75-80. PubMed ID: 11495557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir.
    Wald A; Zeh J; Barnum G; Davis LG; Corey L
    Ann Intern Med; 1996 Jan; 124(1 Pt 1):8-15. PubMed ID: 7503497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.